Dicerna Pharmaceuticals, Inc.
Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA

Abstract:

This invention relates to compounds, compositions, and methods useful for reducing AT3 target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.